Cat. No.: X24-08-YM282
Integrin inhibitor, Cilengitide trifluoroacetate, Purity ≥98%
Synonym: 199807-35-7; EMD 12197; EMD-85189; EMD-121974; NSC-707544; D03497; 2-[(2S,5R,8S,11S)-5-Benzyl-11-[3-(diaminomethylideneamino)propyl]-7-methyl-3,6,9,12,15-pentaoxo-8-propan-2-yl-1,4,7,10,13-pentazacyclopentadec-2-yl]acetic acid; 2,2,2-trifluoroacetic acid
- MDL: MFCD22665738
- CAS Number: 199807-35-7
- Compound CID: 129626550
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Properties
Description
Cilengitide trifluoroacetate, soluble in DMSO and water and insoluble in ethanol, is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin. It targets the αvβ3 receptor (cell-free assay) and αvβ5 receptor (cell-free assay).
Molecular Formula
C29H41N8O9F3
Targets
αvβ3 Receptor (Cell-free assay): 4.1 nM; αvβ5 Receptor (Cell-free assay): 79 nM
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Solubility
In vitro: DMSO: 89 mg/mL (126.66 mM); Water: 7 mg/mL (9.96 mM); Ethanol: insoluble
Applications
Cilengitide trifluoroacetate is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of various cancers by inhibiting integrin-mediated cell adhesion and tumor angiogenesis.
Related Products
- Integrin inhibitor, Zaurategrast, Purity ≥98%
- Integrin inhibitor, Cilengitide, Purity ≥98%
- Integrin inhibitor, Firategrast, Purity ≥98%
- Integrin inhibitor, Pyrintegrin, Purity ≥98%
- Integrin inhibitor, A-205804, Purity ≥98%
- Integrin inhibitor, GLPG0187, Purity ≥98%
